Lv718
4400 积分 2022-09-16 加入
Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune Diseases
54分钟前
已完结
Bioequivalence of two recombinant granulocyte colony-stimulating factor products after subcutaneous injection in healthy volunteers
7天前
已完结
What's next in psoriatic arthritis therapy? A look at the pipeline
7天前
已关闭
A 24‐Day MicroCycle Journey to Interleukin‐17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group Identification
12天前
已完结
Potent Benzothiazole-Triazole RIPK1/RIPK3 Dual-Targeting Inhibitors for the Treatment of Systemic Inflammatory Response Syndrome
13天前
已完结
Thiazole-Linked N-Hydroxypropanamide Derivatives: Selective HDAC6 Inhibitors with Therapeutic Potential for Neurodegenerative Diseases
13天前
已完结
DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity
14天前
已完结
Rational Design and Optimization of Highly Selective CSF1R Inhibitors for the Treatment of Acute Liver Injury
26天前
已完结
Identification of 2,4-Diaminopyrimidine Derivatives as Novel Gut-Restricted Selective JAK1 Inhibitors for the Treatment of Inflammatory Bowel Disease
1个月前
已完结
Discovery of Novel HPK1 Inhibitors via Chemistry-Based Direct-to-Bioassay Screening and SAR Optimization
1个月前
已完结
皖公网安备34019202002308
